Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals

Ivan A. Zaporozhchenko, Evgeny S. Morozkin, Anastasia A. Ponomaryova, Elena Y. Rykova, Nadezhda V. Cherdyntseva, Aleksandr A. Zheravin, Oksana A. Pashkovskaya, Evgeny A. Pokushalov, Valentin V. Vlassov, Pavel P. Laktionov

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    Lung cancer is one of major cancers, and survival of lung cancer patients is dictated by the timely detection and diagnosis. Cell-free circulating miRNAs were proposed as candidate biomarkers for lung cancer. These RNAs are frequently deregulated in lung cancer and can persist in bodily fluids for extended periods of time, shielded from degradation by membrane vesicles and biopolymer complexes. To date, several groups reported the presence of lung tumour-specific subsets of miRNAs in blood. Here we describe the profiling of blood plasma miRNAs in lung cancer patients, healthy individuals and endobronchitis patients using miRCURY LNA miRNA qPCR Serum/Plasma Panel (Exiqon). From 241 ratios differently expressed between cancer patients and healthy individuals 19 miRNAs were selected for verification using the same platform. LASSO-penalized logistic regression model, including 10 miRNA ratios comprised of 14 individual miRNAs discriminated lung cancer patients from both control groups with AUC of 0.979.

    Original languageEnglish
    Article number6348
    JournalScientific Reports
    Volume8
    Issue number1
    DOIs
    Publication statusPublished - 1 Dec 2018

    Fingerprint

    MicroRNAs
    Lung Neoplasms
    Neoplasms
    Logistic Models
    Biopolymers
    Area Under Curve
    Biomarkers
    RNA
    Lung
    Control Groups
    Membranes
    Survival
    Serum

    ASJC Scopus subject areas

    • General

    Cite this

    Zaporozhchenko, I. A., Morozkin, E. S., Ponomaryova, A. A., Rykova, E. Y., Cherdyntseva, N. V., Zheravin, A. A., ... Laktionov, P. P. (2018). Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals. Scientific Reports, 8(1), [6348]. https://doi.org/10.1038/s41598-018-24769-2

    Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals. / Zaporozhchenko, Ivan A.; Morozkin, Evgeny S.; Ponomaryova, Anastasia A.; Rykova, Elena Y.; Cherdyntseva, Nadezhda V.; Zheravin, Aleksandr A.; Pashkovskaya, Oksana A.; Pokushalov, Evgeny A.; Vlassov, Valentin V.; Laktionov, Pavel P.

    In: Scientific Reports, Vol. 8, No. 1, 6348, 01.12.2018.

    Research output: Contribution to journalArticle

    Zaporozhchenko, IA, Morozkin, ES, Ponomaryova, AA, Rykova, EY, Cherdyntseva, NV, Zheravin, AA, Pashkovskaya, OA, Pokushalov, EA, Vlassov, VV & Laktionov, PP 2018, 'Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals', Scientific Reports, vol. 8, no. 1, 6348. https://doi.org/10.1038/s41598-018-24769-2
    Zaporozhchenko IA, Morozkin ES, Ponomaryova AA, Rykova EY, Cherdyntseva NV, Zheravin AA et al. Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals. Scientific Reports. 2018 Dec 1;8(1). 6348. https://doi.org/10.1038/s41598-018-24769-2
    Zaporozhchenko, Ivan A. ; Morozkin, Evgeny S. ; Ponomaryova, Anastasia A. ; Rykova, Elena Y. ; Cherdyntseva, Nadezhda V. ; Zheravin, Aleksandr A. ; Pashkovskaya, Oksana A. ; Pokushalov, Evgeny A. ; Vlassov, Valentin V. ; Laktionov, Pavel P. / Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals. In: Scientific Reports. 2018 ; Vol. 8, No. 1.
    @article{0984530348cd4da9bd8bcef31dce468c,
    title = "Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals",
    abstract = "Lung cancer is one of major cancers, and survival of lung cancer patients is dictated by the timely detection and diagnosis. Cell-free circulating miRNAs were proposed as candidate biomarkers for lung cancer. These RNAs are frequently deregulated in lung cancer and can persist in bodily fluids for extended periods of time, shielded from degradation by membrane vesicles and biopolymer complexes. To date, several groups reported the presence of lung tumour-specific subsets of miRNAs in blood. Here we describe the profiling of blood plasma miRNAs in lung cancer patients, healthy individuals and endobronchitis patients using miRCURY LNA miRNA qPCR Serum/Plasma Panel (Exiqon). From 241 ratios differently expressed between cancer patients and healthy individuals 19 miRNAs were selected for verification using the same platform. LASSO-penalized logistic regression model, including 10 miRNA ratios comprised of 14 individual miRNAs discriminated lung cancer patients from both control groups with AUC of 0.979.",
    author = "Zaporozhchenko, {Ivan A.} and Morozkin, {Evgeny S.} and Ponomaryova, {Anastasia A.} and Rykova, {Elena Y.} and Cherdyntseva, {Nadezhda V.} and Zheravin, {Aleksandr A.} and Pashkovskaya, {Oksana A.} and Pokushalov, {Evgeny A.} and Vlassov, {Valentin V.} and Laktionov, {Pavel P.}",
    year = "2018",
    month = "12",
    day = "1",
    doi = "10.1038/s41598-018-24769-2",
    language = "English",
    volume = "8",
    journal = "Scientific Reports",
    issn = "2045-2322",
    publisher = "Nature Publishing Group",
    number = "1",

    }

    TY - JOUR

    T1 - Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals

    AU - Zaporozhchenko, Ivan A.

    AU - Morozkin, Evgeny S.

    AU - Ponomaryova, Anastasia A.

    AU - Rykova, Elena Y.

    AU - Cherdyntseva, Nadezhda V.

    AU - Zheravin, Aleksandr A.

    AU - Pashkovskaya, Oksana A.

    AU - Pokushalov, Evgeny A.

    AU - Vlassov, Valentin V.

    AU - Laktionov, Pavel P.

    PY - 2018/12/1

    Y1 - 2018/12/1

    N2 - Lung cancer is one of major cancers, and survival of lung cancer patients is dictated by the timely detection and diagnosis. Cell-free circulating miRNAs were proposed as candidate biomarkers for lung cancer. These RNAs are frequently deregulated in lung cancer and can persist in bodily fluids for extended periods of time, shielded from degradation by membrane vesicles and biopolymer complexes. To date, several groups reported the presence of lung tumour-specific subsets of miRNAs in blood. Here we describe the profiling of blood plasma miRNAs in lung cancer patients, healthy individuals and endobronchitis patients using miRCURY LNA miRNA qPCR Serum/Plasma Panel (Exiqon). From 241 ratios differently expressed between cancer patients and healthy individuals 19 miRNAs were selected for verification using the same platform. LASSO-penalized logistic regression model, including 10 miRNA ratios comprised of 14 individual miRNAs discriminated lung cancer patients from both control groups with AUC of 0.979.

    AB - Lung cancer is one of major cancers, and survival of lung cancer patients is dictated by the timely detection and diagnosis. Cell-free circulating miRNAs were proposed as candidate biomarkers for lung cancer. These RNAs are frequently deregulated in lung cancer and can persist in bodily fluids for extended periods of time, shielded from degradation by membrane vesicles and biopolymer complexes. To date, several groups reported the presence of lung tumour-specific subsets of miRNAs in blood. Here we describe the profiling of blood plasma miRNAs in lung cancer patients, healthy individuals and endobronchitis patients using miRCURY LNA miRNA qPCR Serum/Plasma Panel (Exiqon). From 241 ratios differently expressed between cancer patients and healthy individuals 19 miRNAs were selected for verification using the same platform. LASSO-penalized logistic regression model, including 10 miRNA ratios comprised of 14 individual miRNAs discriminated lung cancer patients from both control groups with AUC of 0.979.

    UR - http://www.scopus.com/inward/record.url?scp=85045919933&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85045919933&partnerID=8YFLogxK

    U2 - 10.1038/s41598-018-24769-2

    DO - 10.1038/s41598-018-24769-2

    M3 - Article

    VL - 8

    JO - Scientific Reports

    JF - Scientific Reports

    SN - 2045-2322

    IS - 1

    M1 - 6348

    ER -